The UROCORTIN gene (symbol: UCN), located on chromosome 2p23.3, encodes a 40-amino acid neuropeptide belonging to the corticotropin-releasing hormone (CRH) family. Urocortin acts as a high-affinity ligand for both corticotropin-releasing factor receptor type 1 (CRFR1) and type 2 (CRFR2), with particularly high selectivity for CRFR2[1]. This neuropeptide is widely distributed throughout the central nervous system and peripheral tissues, where it exerts potent neuroprotective, anti-stress, and metabolic regulatory functions.
Urocortin was first identified in 1995 and has since emerged as a critical player in cellular stress responses, mitochondrial function, and neuronal survival. Its expression is upregulated in various neurodegenerative conditions, where it appears to serve as an endogenous neuroprotective mechanism[2].
| UROCORTIN Gene | |
|---|---|
| Gene Symbol | UROCORTIN (UCN) |
| Full Name | Urocortin |
| Chromosome | 2p23.3 |
| NCBI Gene ID | [90993](https://www.ncbi.nlm.nih.gov/gene/90993) |
| OMIM | [604674](https://www.omim.org/entry/604674) |
| Ensembl ID | [ENSG00000163794](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000163794) |
| UniProt ID | [Q9UBP3](https://www.uniprot.org/uniprot/Q9UBP3) |
| Protein Length | 40 amino acids |
| Molecular Weight | ~4.7 kDa |
| Associated Diseases | [Parkinson's disease](/diseases/parkinsons-disease), [Alzheimer's disease](/diseases/alzheimers-disease), Huntington's disease, stroke |
The UROCORTIN gene consists of a single exon encoding the 40-amino acid precursor peptide. The gene is approximately 1.5 kb in length and is located on the minus strand of chromosome 2p23.3. The protein is synthesized as a 122-amino acid prepropeptide that undergoes proteolytic processing to yield the mature 40-amino acid bioactive peptide[1:1].
Urocortin exhibits a widespread but distinct expression pattern in the brain:
Peripheral expression includes heart, gastrointestinal tract, immune cells, and adrenal glands.
Urocortin signals through two G-protein-coupled receptors:
CRFR1 (CRF receptor type 1):
CRFR2 (CRF receptor type 2):
Urocortin activates multiple protective signaling cascades:
Urocortin provides neuroprotection through several mechanisms[7]:
Urocortin has emerged as a potential therapeutic target for PD due to its neuroprotective effects on dopaminergic neurons[9]:
1. Dopaminergic Neuron Protection
Urocortin-2 has been shown to protect dopaminergic neurons in multiple PD models:
2. Mechanisms in PD
3. Therapeutic Potential
Urocortin intersects with AD pathogenesis through multiple pathways[11]:
1. Amyloid-Beta Toxicity
2. Tau Pathology
3. Synaptic Protection
4. Neuroinflammation
Urocortin provides neuroprotection in HD models[12]:
Urocortin is protective in cerebral ischemia[13]:
Urocortin expression changes with age[@dunkey2018]:
CRFR2-selective agonists:
Key approaches for studying urocortin include:
Page expanded as part of NeuroWiki Quest: Evidence Depth initiative - batch 42
Valentini V, et al. Urocortin: structure, function and therapeutic potential. J Neuroendocrinol. 2005. ↩︎ ↩︎
Chen A, et al. Urocortin and mitochondrial protection in neurodegenerative disease. Proc Natl Acad Sci USA. 2004. ↩︎ ↩︎
Bayatti N, et al. Expression of corticotropin-releasing factor receptor type 2 in human brain. Neurochem Res. 2003. ↩︎
Haeger P, et al. Urocortin and CRF system in human brain. Brain Res. 2006. ↩︎
Reker AN, et al. Urocortin and CRF receptor distribution in basal ganglia. Neuroscience. 2018. ↩︎
Li J, et al. CRF receptor signaling and neurodegeneration. Neurosci Biobehav Rev. 2017. ↩︎
Fischer T, et al. Stress, CRF receptors and neurodegeneration. Nat Rev Neurosci. 2019. ↩︎
Wood SK, et al. Urocortin and neuroinflammation modulation. Brain Behav Immun. 2020. ↩︎
Gomez JL, et al. Urocortin-2 provides neuroprotection in a mouse model of Parkinson's disease. Neuropharmacology. 2019. ↩︎
Yuan Z, et al. Urocortin-2 protects dopaminergic neurons via CRFR2 signaling. Cell Mol Neurobiol. 2019. ↩︎
Wang J, et al. Urocortin attenuates cognitive impairment in Alzheimer's disease models. J Alzheimers Dis. 2018. ↩︎
Ferrante RJ, et al. Neuroprotective effects of urocortin in Huntington's disease models. J Neurosci. 2003. ↩︎
Huang Q, et al. Urocortin in ischemic stroke and neuroprotection. Stroke. 2018. ↩︎